Selected research
Industry Research
Digestive Drugs Industry Research Report 2026
Market perspective
The global Digestive Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digestive Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digestive Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digestive Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digestive Drugs include Eisai, Teva, Sanofi, Johnson & Johnson, Pfizer, Bayer, Jiangsu Aosaikang Pharma, AstraZeneca and Sumitomo, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digestive Drugs market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digestive Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digestive Drugs Market by Company
Eisai
Teva
Sanofi
Johnson & Johnson
Pfizer
Bayer
Jiangsu Aosaikang Pharma
AstraZeneca
Sumitomo
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Cadila Pharmaceuticals
Digestive Drugs Segment by Type
OTC
Rx
Digestive Drugs Segment by Application
Hospital
Clinic
Digestive Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digestive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digestive Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- OTC
- Rx
Applications
- Hospital
- Clinic
Companies covered
- Eisai
- Teva
- Sanofi
- Johnson & Johnson
- Pfizer
- Bayer
- Jiangsu Aosaikang Pharma
- AstraZeneca
- Sumitomo
- Kyowa Kirin Pharmaceuticals
- Hanmi Pharm
- Cadila Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digestive Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 OTC
- 2.2.3 Rx
- 2.3 Digestive Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Digestive Drugs Breakdown Data by Type
- 3.1 Global Digestive Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Digestive Drugs Forecasted Market Size by Type (2027-2032)
4 Digestive Drugs Breakdown Data by Application
- 4.1 Global Digestive Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Digestive Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digestive Drugs Market Perspective (2021-2032)
- 5.2 Global Digestive Drugs Growth Trends by Region
- 5.2.1 Global Digestive Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digestive Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Digestive Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Digestive Drugs Market Dynamics
- 5.3.1 Digestive Drugs Industry Trends
- 5.3.2 Digestive Drugs Market Drivers
- 5.3.3 Digestive Drugs Market Challenges
- 5.3.4 Digestive Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digestive Drugs Players by Revenue
- 6.1.1 Global Top Digestive Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Digestive Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Digestive Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digestive Drugs Head Office and Area Served
- 6.4 Global Digestive Drugs Players, Product Type & Application
- 6.5 Global Digestive Drugs Manufacturers Established Date
- 6.6 Global Digestive Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digestive Drugs Market Size (2021-2032)
- 7.2 North America Digestive Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digestive Drugs Market Size by Country (2021-2026)
- 7.4 North America Digestive Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digestive Drugs Market Size (2021-2032)
- 8.2 Europe Digestive Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digestive Drugs Market Size by Country (2021-2026)
- 8.4 Europe Digestive Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digestive Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Digestive Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digestive Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digestive Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digestive Drugs Market Size (2021-2032)
- 10.2 South America Digestive Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digestive Drugs Market Size by Country (2021-2026)
- 10.4 South America Digestive Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digestive Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Digestive Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digestive Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digestive Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eisai
- 12.1.1 Eisai Company Information
- 12.1.2 Eisai Business Overview
- 12.1.3 Eisai Revenue in Digestive Drugs Business (2021-2026)
- 12.1.4 Eisai Digestive Drugs Product Portfolio
- 12.1.5 Eisai Recent Developments
- 12.2 Teva
- 12.2.1 Teva Company Information
- 12.2.2 Teva Business Overview
- 12.2.3 Teva Revenue in Digestive Drugs Business (2021-2026)
- 12.2.4 Teva Digestive Drugs Product Portfolio
- 12.2.5 Teva Recent Developments
- 12.3 Sanofi
- 12.3.1 Sanofi Company Information
- 12.3.2 Sanofi Business Overview
- 12.3.3 Sanofi Revenue in Digestive Drugs Business (2021-2026)
- 12.3.4 Sanofi Digestive Drugs Product Portfolio
- 12.3.5 Sanofi Recent Developments
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Information
- 12.4.2 Johnson & Johnson Business Overview
- 12.4.3 Johnson & Johnson Revenue in Digestive Drugs Business (2021-2026)
- 12.4.4 Johnson & Johnson Digestive Drugs Product Portfolio
- 12.4.5 Johnson & Johnson Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in Digestive Drugs Business (2021-2026)
- 12.5.4 Pfizer Digestive Drugs Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Digestive Drugs Business (2021-2026)
- 12.6.4 Bayer Digestive Drugs Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Jiangsu Aosaikang Pharma
- 12.7.1 Jiangsu Aosaikang Pharma Company Information
- 12.7.2 Jiangsu Aosaikang Pharma Business Overview
- 12.7.3 Jiangsu Aosaikang Pharma Revenue in Digestive Drugs Business (2021-2026)
- 12.7.4 Jiangsu Aosaikang Pharma Digestive Drugs Product Portfolio
- 12.7.5 Jiangsu Aosaikang Pharma Recent Developments
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Information
- 12.8.2 AstraZeneca Business Overview
- 12.8.3 AstraZeneca Revenue in Digestive Drugs Business (2021-2026)
- 12.8.4 AstraZeneca Digestive Drugs Product Portfolio
- 12.8.5 AstraZeneca Recent Developments
- 12.9 Sumitomo
- 12.9.1 Sumitomo Company Information
- 12.9.2 Sumitomo Business Overview
- 12.9.3 Sumitomo Revenue in Digestive Drugs Business (2021-2026)
- 12.9.4 Sumitomo Digestive Drugs Product Portfolio
- 12.9.5 Sumitomo Recent Developments
- 12.10 Kyowa Kirin Pharmaceuticals
- 12.10.1 Kyowa Kirin Pharmaceuticals Company Information
- 12.10.2 Kyowa Kirin Pharmaceuticals Business Overview
- 12.10.3 Kyowa Kirin Pharmaceuticals Revenue in Digestive Drugs Business (2021-2026)
- 12.10.4 Kyowa Kirin Pharmaceuticals Digestive Drugs Product Portfolio
- 12.10.5 Kyowa Kirin Pharmaceuticals Recent Developments
- 12.11 Hanmi Pharm
- 12.11.1 Hanmi Pharm Company Information
- 12.11.2 Hanmi Pharm Business Overview
- 12.11.3 Hanmi Pharm Revenue in Digestive Drugs Business (2021-2026)
- 12.11.4 Hanmi Pharm Digestive Drugs Product Portfolio
- 12.11.5 Hanmi Pharm Recent Developments
- 12.12 Cadila Pharmaceuticals
- 12.12.1 Cadila Pharmaceuticals Company Information
- 12.12.2 Cadila Pharmaceuticals Business Overview
- 12.12.3 Cadila Pharmaceuticals Revenue in Digestive Drugs Business (2021-2026)
- 12.12.4 Cadila Pharmaceuticals Digestive Drugs Product Portfolio
- 12.12.5 Cadila Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst